Wentao Zhang, Co-CEO

Professional Overview

Wentao Zhang is the Co-CEO of Frontage Laboratories, Inc., a leading global contract research organization (CRO) providing integrated, science-driven drug discovery, development, and manufacturing services. With a strong background in the pharmaceutical and biotechnology industries, Wentao brings a wealth of expertise in strategic leadership, global drug discovery services, and driving innovative solutions to advance the development of new therapies.

Experience Summary

Current Role

As the Co-CEO of Frontage Laboratories, Wentao is responsible for setting the strategic vision and direction of the company, ensuring the seamless execution of global operations, and fostering a culture of innovation and excellence. In this role, he works closely with the leadership team to expand the company's service offerings, strengthen client partnerships, and drive continuous improvements to deliver exceptional value to Frontage's diverse client base.

Career Progression

Prior to his current role, Wentao served as the Chief Strategy Officer at Frontage Laboratories, where he was instrumental in shaping the company's long-term growth strategies and overseeing the integration of the Quintara Discovery (QDI) business, which he had founded and led as President. Before joining Frontage, Wentao held the position of EVP of the Frontage Global Drug Discovery Services (GDDS) division, where he successfully grew the company's global footprint and capabilities in early-stage drug discovery.

Wentao's career began at Exelixis, where he held the role of Senior Director, contributing his expertise in drug discovery and development. He also gained valuable experience as a Staff Scientist at Genelabs Technologies and as a Postdoctoral Fellow at the University of California-Berkeley.

Academic Background

Wentao holds a Ph.D. in Biochemistry and Molecular Biology from the University of California-Berkeley, where he specialized in structural biology and drug discovery.

Areas of Expertise

• Strategic leadership and business development in the CRO industry

• Extensive experience in global drug discovery and early-stage drug development

• Expertise in integrating and scaling acquired businesses for growth

• Proven track record in driving innovation and operational excellence

• Strong scientific and technical acumen in the pharmaceutical and biotechnology sectors

Professional Impact

Under Wentao's leadership, Frontage Laboratories has expanded its global reach, diversified its service offerings, and solidified its reputation as a trusted partner in the drug discovery and development ecosystem. His strategic vision and technical expertise have contributed to the successful delivery of numerous complex projects, helping clients accelerate their drug pipelines and improve patient outcomes.

Conclusion

Wentao Zhang's impressive career journey, spanning senior leadership roles in prominent pharmaceutical and biotechnology companies, positions him as a seasoned executive with a deep understanding of the industry's evolving landscape. As the Co-CEO of Frontage Laboratories, he is poised to drive the company's continued growth and solidify its position as a global leader in contract research and development services.